Provided by Tiger Fintech (Singapore) Pte. Ltd.

iBio

1.24
-0.0500-3.88%
Pre-market: 1.250.0100+0.81%04:34 EST
Volume:851.29K
Turnover:1.05M
Market Cap:25.12M
PE:-0.71
High:1.28
Open:1.26
Low:1.21
Close:1.29
52wk High:6.89
52wk Low:0.5562
Shares:20.25M
Float Shares:18.61M
Volume Ratio:0.49
T/O Rate:4.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7504
EPS(LYR):-1.7504
ROE:-101.52%
ROA:-44.79%
PB:1.69
PE(LYR):-0.71

Loading ...

iBio Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Nov 07

Oppenheimer Reaffirms Their Buy Rating on Ibio (IBIO)

TIPRANKS
·
Nov 06

iBio Regains Nasdaq Compliance with Bid Price Rule

TIPRANKS
·
Nov 05

iBio management to meet with Oppenheimer

TIPRANKS
·
Nov 03

iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance

GlobeNewswire
·
Oct 30

iBio price target raised to $6 from $5 at Oppenheimer

TIPRANKS
·
Oct 30

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire
·
Oct 23

Oppenheimer Initiates Coverage on iBio With Outperform Rating, $5 Price Target

MT Newswires Live
·
Oct 21

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025

GlobeNewswire
·
Oct 21

U.S. RESEARCH ROUNDUP-Block, Morgan Stanley, W R Berkley

Reuters
·
Oct 21

Ibio Inc : Oppenheimer Initiates Coverage With Outperform Rating; Price Target $5

THOMSON REUTERS
·
Oct 21

iBio initiated with an Outperform at Oppenheimer

TIPRANKS
·
Oct 21

iBio Initiated at Outperform by Leerink Partners

Dow Jones
·
Oct 17

Leerink Initiates iBio at Outperform With $2 Price Target

MT Newswires Live
·
Oct 17

iBio initiated with an Outperform at Leerink

TIPRANKS
·
Oct 17

Ibio Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $2

THOMSON REUTERS
·
Oct 17

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09

iBio Inc. Announces Date for 2025 Annual Meeting of Stockholders

Reuters
·
Oct 07

Ibio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Sep 05

Press Release: iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Sep 05